Margherita Pieri

696 total citations
7 papers, 591 citations indexed

About

Margherita Pieri is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Margherita Pieri has authored 7 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 3 papers in Clinical Psychology and 2 papers in Cognitive Neuroscience. Recurrent topics in Margherita Pieri's work include Neurotransmitter Receptor Influence on Behavior (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Psychedelics and Drug Studies (3 papers). Margherita Pieri is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (3 papers), Neuroscience and Neuropharmacology Research (3 papers) and Psychedelics and Drug Studies (3 papers). Margherita Pieri collaborates with scholars based in Switzerland and United States. Margherita Pieri's co-authors include L. Pieri, W. Haefely, R. Schaffner, R. Cumin, E. P. Bonetti, Elkan Gamzu, M. Da Prada, R. Scherschlicht, Da Prada M and Arnold B. Davidson and has published in prestigious journals such as Nature, Annals of the New York Academy of Sciences and Life Sciences.

In The Last Decade

Margherita Pieri

7 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margherita Pieri Switzerland 6 383 144 105 73 63 7 591
Arnold B. Davidson United States 11 196 0.5× 114 0.8× 130 1.2× 74 1.0× 81 1.3× 16 561
Schellekens Kh 9 410 1.1× 94 0.7× 224 2.1× 33 0.5× 146 2.3× 10 792
Joel Elkes United States 10 301 0.8× 217 1.5× 99 0.9× 79 1.1× 99 1.6× 25 690
William Schallek United States 15 496 1.3× 217 1.5× 172 1.6× 23 0.3× 167 2.7× 36 919
D. Fontana United States 11 534 1.4× 153 1.1× 377 3.6× 50 0.7× 69 1.1× 19 908
R. Scherschlicht Switzerland 13 505 1.3× 294 2.0× 161 1.5× 14 0.2× 87 1.4× 20 861
M.R. Dzoljic Netherlands 17 609 1.6× 160 1.1× 348 3.3× 47 0.6× 60 1.0× 42 1.0k
J R Boissier France 18 584 1.5× 171 1.2× 296 2.8× 30 0.4× 91 1.4× 58 1.1k
E.F. Domino United States 9 323 0.8× 131 0.9× 252 2.4× 41 0.6× 53 0.8× 10 844
Harold L. Goldberg United States 9 302 0.8× 133 0.9× 134 1.3× 88 1.2× 138 2.2× 22 658

Countries citing papers authored by Margherita Pieri

Since Specialization
Citations

This map shows the geographic impact of Margherita Pieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margherita Pieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margherita Pieri more than expected).

Fields of papers citing papers by Margherita Pieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margherita Pieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margherita Pieri. The network helps show where Margherita Pieri may publish in the future.

Co-authorship network of co-authors of Margherita Pieri

This figure shows the co-authorship network connecting the top 25 collaborators of Margherita Pieri. A scholar is included among the top collaborators of Margherita Pieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margherita Pieri. Margherita Pieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Schaffner, R., et al.. (1982). Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine.. PubMed. 31. 249–63. 12 indexed citations
2.
Bonetti, E. P., L. Pieri, R. Cumin, et al.. (1982). Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects. Psychopharmacology. 78(1). 8–18. 301 indexed citations
3.
Pieri, L., R. Schaffner, R. Scherschlicht, et al.. (1981). Pharmacology of midazolam.. PubMed. 31(12a). 2180–201. 127 indexed citations
4.
Prada, M. Da, L. Pieri, H. H. Keller, Margherita Pieri, & E. P. Bonetti. (1978). EFFECTS OF 5,6‐DIHYDROXYTRYPTAMINE AND 5,7‐DIHYDROXYTRYPTAMINE ON THE RAT CENTRAL NERVOUS SYSTEM AFTER INTRAVENTRICULAR OR INTRACEREBRAL APPLICATION AND ON BLOOD PLATELETS IN VITRO. Annals of the New York Academy of Sciences. 305(1). 595–620. 22 indexed citations
5.
Pieri, Margherita, R. Schaffner, L. Pieri, M. Da Prada, & W. Haefely. (1978). Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD. Life Sciences. 22(18). 1615–1622. 30 indexed citations
6.
Pieri, L., Margherita Pieri, & W. Haefely. (1975). LSD and dopamine receptors (reply). Nature. 257(5521). 70–70. 3 indexed citations
7.
Pieri, L., Margherita Pieri, & W. Haefely. (1974). LSD as an agonist of dopamine receptors in the striatum. Nature. 252(5484). 586–588. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026